SMA News Forums Forums SMA News Today Multimedia SMA News Today’s YouTube The Morale Monologue Episode 5

  • The Morale Monologue Episode 5

    Posted by michael-morale on July 24, 2018 at 5:26 pm

    In this episode of the Morale Monologue, I’m giving everyone information regarding Avexis Pharmaceutical, and their announcement regarding their expansion of operations to North Carolina. Illinois-based AveXis, a Novartis company, is developing AVXS-101, a proprietary gene therapy that could prove to be a transformative treatment for babies and children with SMA types 1, 2 and 3. These treatments will also benefit adults with SMA in the coming future. AveXis is anticipated to invest about $55 million into the new facility and open up about 200 new jobs, giving a boost to the state’s economy while improving its capabilities to manufacture therapies targeting rare neurological and genetic diseases, including spinal muscular atrophy (SMA).

    michael-morale replied 5 years, 10 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.